Molecular Pathology and Pharmacogenetic Group, Clinical Analysis Department, Santa Lucía General University Hospital (HGUSL), 30202 Cartagena, Spain.
Hum Immunol. 2013 Oct;74(10):1352-6. doi: 10.1016/j.humimm.2013.07.006. Epub 2013 Jul 31.
Squamous intraepithelial lesions (SIL) and cervical cancer are primary due to suboptimal host-dependent immune response against human papillomavirus (HPV). Natural killer cells (NK) are innate-immune response components against virus and tumors. We studied whether the null allele of NKG2C NK cell receptor could be associated with low-grade (LSIL) to high-grade SIL (HSIL) transition or likelihood of HPV infection. Eight-hundred and sixty-seven subjects (263 LSIL, 309 HSIL and 295 controls) were genotyped for NKG2C using a novel multiplex PCR protocol. HPV genotype information was obtained from the cases. NKG2C genotype distributions in LSIL were WT/WT: 69.2%, WT/null: 26.2% and null/null: 4.6%; whereas in HSIL were WT/WT: 65.4%, WT/null: 28.5% and null/null: 6.1% and no statistical differences were observed (LSIL vs. HSIL p=0.541; LSIL vs. controls p=0.230; HSIL vs. controls p=0.624) nor when restricting to HPV positive, HR-HPV nor co-infection. This study demonstrates that NKG2Cnull does not seem to constitute a risk factor for HPV-induced cervical lesions.
鳞状上皮内病变(SIL)和宫颈癌主要是由于宿主对人乳头瘤病毒(HPV)的免疫反应不佳所致。自然杀伤细胞(NK)是针对病毒和肿瘤的固有免疫反应成分。我们研究了 NK 细胞受体 NKG2C 的无效等位基因是否与低级别(LSIL)到高级别 SIL(HSIL)的转变或 HPV 感染的可能性相关。使用新型多重 PCR 方案对 867 名受试者(263 名 LSIL、309 名 HSIL 和 295 名对照)进行了 NKG2C 基因分型。从病例中获得了 HPV 基因型信息。LSIL 中的 NKG2C 基因型分布为 WT/WT:69.2%,WT/null:26.2%和 null/null:4.6%;而 HSIL 中为 WT/WT:65.4%,WT/null:28.5%和 null/null:6.1%,未观察到统计学差异(LSIL 与 HSIL 比较 p=0.541;LSIL 与对照比较 p=0.230;HSIL 与对照比较 p=0.624),也没有观察到 HPV 阳性、高危型 HPV 或合并感染时存在差异。本研究表明,NKG2Cnull 似乎不会构成 HPV 引起的宫颈病变的危险因素。